Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lipocine (LPCN) Times Interest Earned (2018 - 2022)

Lipocine's Times Interest Earned history spans 5 years, with the latest figure at -$2.9 million for Q3 2022.

  • For Q3 2022, Times Interest Earned fell 3679014.54% year-over-year to -$2.9 million; the TTM value through Jun 2023 reached -$13.8 million, down 208018609.46%, while the annual FY2022 figure was -$447.24, 68168.09% down from the prior year.
  • Times Interest Earned reached -$2.9 million in Q3 2022 per LPCN's latest filing, down from -$466.11 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $296.57 in Q4 2021 to a low of -$2.9 million in Q3 2022.
  • Average Times Interest Earned over 5 years is -$161121.1, with a median of -$39.81 recorded in 2020.
  • Peak YoY movement for Times Interest Earned: skyrocketed 601.1% in 2021, then crashed 3679014.54% in 2022.
  • A 5-year view of Times Interest Earned shows it stood at -$10.77 in 2018, then plummeted by 106.81% to -$22.26 in 2019, then plummeted by 165.82% to -$59.18 in 2020, then soared by 601.1% to $296.57 in 2021, then plummeted by 977745.56% to -$2.9 million in 2022.
  • Per Business Quant, the three most recent readings for LPCN's Times Interest Earned are -$2.9 million (Q3 2022), -$466.11 (Q2 2022), and -$160.36 (Q1 2022).